KAPOSI SARCOMA
Clinical trials for KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for rare HIV-Linked cancer
Disease control OngoingThis early-phase trial tests whether combining two anti-cancer drugs, pomalidomide and liposomal doxorubicin, can safely treat advanced or hard-to-treat Kaposi sarcoma. The study includes 62 adults, some with HIV. Participants receive the drugs in 4-week cycles and are monitored …
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Cancer drug combo tested for rare skin cancer – but study never started
Disease control TerminatedThis study aimed to test a combination of two drugs, pembrolizumab and lenvatinib, in people with classic Kaposi sarcoma that had not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemotherapy. However, the study …
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Hidden bone loss in HIV and cancer patients under the microscope
Knowledge-focused OngoingThis study examines bone mineral density loss in adults with HIV and Kaposi sarcoma or other KSHV-related cancers. Researchers will review past CT scans from 40 participants treated at the NIH between 2005 and 2020. The goal is to identify factors linked to bone loss, which is co…
Matched conditions: KAPOSI SARCOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 16, 2026 23:37 UTC
-
New study aims to personalize kaposi sarcoma treatment for HIV patients in africa
Knowledge-focused OngoingThis study follows 127 people with HIV-related Kaposi sarcoma in Malawi and South Africa who are receiving standard chemotherapy. Researchers want to understand why some patients respond better than others, especially based on gender and virus levels. The goal is to find ways to …
Matched conditions: KAPOSI SARCOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:01 UTC